Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Stroke

Free Subscription Articles published in Lancet Retrieve available abstracts of 95 articles: HTML format

Single Articles

December 2025
1. 
   Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
   Lancet. 2025;404:2543-2583.
   PubMed     Abstract available
   
   
   
2. KEDHI E, Hermanides RS, Dambrink JE, Singh SK, et al
   TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and c
   Lancet. 2025;404:2593-2602.
   PubMed     Abstract available
   
   
   June 2025
3. DENT E, Clegg A, Roller-Wirnsberger R, Vetrano DL, et al
   Reorienting frailty in clinical practice, public health, and policy: the Lancet Commission on Frailty.
   Lancet. 2025 Jun 5:S0140-6736(25)01101-8. doi: 10.1016/S0140-6736(25)01101.
   PubMed    
   
   
   May 2025
4. ASHCRAFT S
   Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.
   Lancet. 2025;405:1884-1885.
   PubMed    
   
   
   
5. SHNEIDER NA, Harms MB, Korobeynikov VA, Rifai OM, et al
   Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
   Lancet. 2025 May 22:S0140-6736(25)00513-6. doi: 10.1016/S0140-6736(25)00513.
   PubMed     Abstract available
   
   
   
6. ANDERSON CS, Summers D, Ouyang M, Sui Y, et al
   Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferio
   Lancet. 2025 May 20:S0140-6736(25)00549-5. doi: 10.1016/S0140-6736(25)00549.
   PubMed     Abstract available
   
   
   
7. MAKKAR RR, Ramana RK, Gnall E, Ramlawi B, et al
   ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial.
   Lancet. 2025 May 20:S0140-6736(25)00319-8. doi: 10.1016/S0140-6736(25)00319.
   PubMed     Abstract available
   
   
   
8. SONG L, Li Q, Anderson CS
   Traditional Chinese medicine for acute intracerebral haemorrhage - Authors' reply.
   Lancet. 2025;405:1741-1742.
   PubMed    
   
   
   March 2025
9. CHOI KH, Park YH, Lee JY, Jeong JO, et al
   Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
   Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449.
   PubMed     Abstract available
   
   
   
10. FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al
    Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505.
    PubMed     Abstract available
    
    
    
11. 
    Global, regional, and national burden of household air pollution, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2025 Mar 18:S0140-6736(24)02840-X. doi: 10.1016/S0140-6736(24)02840.
    PubMed     Abstract available
    
    
    February 2025
12. 
    Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
    Lancet. 2025 Feb 28:S0140-6736(25)00355-1. doi: 10.1016/S0140-6736(25)00355.
    PubMed     Abstract available
    
    
    
13. 
    Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
    Lancet. 2025 Feb 28:S0140-6736(25)00397-6. doi: 10.1016/S0140-6736(25)00397.
    PubMed     Abstract available
    
    
    
14. SALMAN RA, Shoamanesh A
    Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage.
    Lancet. 2025 Feb 26:S0140-6736(25)00366-6. doi: 10.1016/S0140-6736(25)00366.
    PubMed    
    
    
    
15. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available
    
    
    
16. CHRISTENSON J, Hill MD, Swartz RH, Adams C, et al
    Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
    Lancet. 2025;405:571-582.
    PubMed     Abstract available
    
    
    
17. HILL MD, Goyal M, Demchuk AM, Menon BK, et al
    Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2025;405:560-570.
    PubMed     Abstract available
    
    
    
18. KOOHI N, Simonyan S, Joffily L, Simister R, et al
    Testing hearing in suspected stroke: a diagnostic opportunity.
    Lancet. 2025;405:540-541.
    PubMed    
    
    
    
19. LIBERMAN AL, Levine SR
    Ischaemic brain neuroprotection: a true therapeutic frontier?
    Lancet. 2025;405:519-521.
    PubMed    
    
    
    
20. LI W, Lan J, Wei M, Liu L, et al
    Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.
    Lancet. 2025;405:486-497.
    PubMed     Abstract available
    
    
    
21. DIPPEL DWJ, Janssen PM
    Effect of normobaric hyperoxia in ischaemic stroke.
    Lancet. 2025;405:442-443.
    PubMed    
    
    
    January 2025
22. WILLIAMS MC, Wereski R, Tuck C, Adamson PD, et al
    Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
    Lancet. 2025;405:329-337.
    PubMed     Abstract available
    
    
    December 2024
23. NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al
    Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.
    Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820.
    PubMed     Abstract available
    
    
    
24. HO JK, Hankey GJ
    Endovascular therapy for ischaemic stroke due to vertebrobasilar artery occlusion.
    Lancet. 2024 Dec 11:S0140-6736(24)02137-8. doi: 10.1016/S0140-6736(24)02137.
    PubMed    
    
    
    
25. 
    Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2341-2370.
    PubMed     Abstract available
    
    
    
26. 
    The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2314-2340.
    PubMed     Abstract available
    
    
    November 2024
27. DHILLON PS, Nguyen TN
    Temporary blood flow arrest during endovascular thrombectomy for acute ischaemic stroke.
    Lancet. 2024 Nov 20:S0140-6736(24)02461-9. doi: 10.1016/S0140-6736(24)02461.
    PubMed    
    
    
    
28. LIU J, Zhou Y, Zhang L, Li Z, et al
    Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315.
    PubMed     Abstract available
    
    
    
29. 
    National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.
    Lancet. 2024 Nov 12:S0140-6736(24)01548-4. doi: 10.1016/S0140-6736(24)01548.
    PubMed     Abstract available
    
    
    
30. WU S
    Integrative medicine for the treatment of stroke.
    Lancet. 2024 Nov 12:S0140-6736(24)02257-8. doi: 10.1016/S0140-6736(24)02257.
    PubMed    
    
    
    
31. GUO J, Chen X, Wu M, Wang D, et al
    Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial.
    Lancet. 2024 Nov 12:S0140-6736(24)02261-X. doi: 10.1016/S0140-6736(24)02261.
    PubMed     Abstract available
    
    
    
32. 
    Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925.
    PubMed     Abstract available
    
    
    
33. THOMALLA G, Bonekamp S, Fiehler J, Bendszus M, et al
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial - Authors' reply.
    Lancet. 2024;404:1729-1730.
    PubMed    
    
    
    
34. JHOU HJ, Yang LY, Chen PH
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728.
    PubMed    
    
    
    
35. WANG Z, Huang K, Huang ZX
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728-1729.
    PubMed    
    
    
    
36. BROOCKS G, Kemmling A
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1727-1728.
    PubMed    
    
    
    October 2024
37. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available
    
    
    
38. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    
    
    
    September 2024
39. NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al
    Endovascular management of acute stroke.
    Lancet. 2024;404:1265-1278.
    PubMed     Abstract available
    
    
    
40. NARAGHI K, Marzo-Ortega H
    Progressive cervical osteophytosis and dysphagia associated with isotretinoin treatment for rosacea.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
41. 
    Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01867-1. doi: 10.1016/S0140-6736(24)01867.
    PubMed     Abstract available
    
    
    August 2024
42. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
    Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
    PubMed     Abstract available
    
    
    
43. VALGIMIGLI M, Hong SJ, Gragnano F, Chalkou K, et al
    De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
    Lancet. 2024 Aug 30:S0140-6736(24)01616-7. doi: 10.1016/S0140-6736(24)01616.
    PubMed     Abstract available
    
    
    
44. JHUND PS, Talebi A, Henderson AD, Claggett BL, et al
    Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.
    Lancet. 2024 Aug 30:S0140-6736(24)01733-1. doi: 10.1016/S0140-6736(24)01733.
    PubMed     Abstract available
    
    
    
45. KOSIBOROD MN, Deanfield J, Pratley R, Borlaug BA, et al
    Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
    Lancet. 2024 Aug 29:S0140-6736(24)01643-X. doi: 10.1016/S0140-6736(24)01643.
    PubMed     Abstract available
    
    
    
46. DEANFIELD J, Verma S, Scirica BM, Kahn SE, et al
    Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
    Lancet. 2024;404:773-786.
    PubMed     Abstract available
    
    
    
47. JAVED S, Zaidi DA, Yaqoob E
    Addressing the deficiencies in stroke care in Pakistan.
    Lancet. 2024;404:651-652.
    PubMed    
    
    
    
48. COUTTS SB, Sprigg N
    Human rights considerations are key when choosing a conference location.
    Lancet. 2024 Aug 16:S0140-6736(24)01503-4. doi: 10.1016/S0140-6736(24)01503.
    PubMed    
    
    
    
49. MANLEY GT, Maas AI
    The Glasgow Coma Scale at 50: looking back and forward.
    Lancet. 2024 Aug 14:S0140-6736(24)01596-4. doi: 10.1016/S0140-6736(24)01596.
    PubMed    
    
    
    July 2024
50. JOUNDI RA, Hu B, Rangarajan S, Leong DP, et al
    Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study.
    Lancet. 2024 Jul 25:S0140-6736(24)01050-X. doi: 10.1016/S0140-6736(24)01050.
    PubMed     Abstract available
    
    
    June 2024
51. LIU J, Li Y, Ge J, Yan X, et al
    Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
    PubMed     Abstract available
    
    
    
52. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available
    
    
    
53. KATSANOS AH, Shoamanesh A
    Colchicine for the prevention of vascular events after non-cardioembolic stroke.
    Lancet. 2024 Jun 7:S0140-6736(24)01096-1. doi: 10.1016/S0140-6736(24)01096.
    PubMed    
    
    
    May 2024
54. BAUMBACH A, van Royen N, Amat-Santos IJ, Hudec M, et al
    LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
    Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821.
    PubMed     Abstract available
    
    
    
55. 
    Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2204-2256.
    PubMed     Abstract available
    
    
    
56. 
    Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2162-2203.
    PubMed     Abstract available
    
    
    
57. ADLER AI, Coleman RL, Leal J, Whiteley WN, et al
    Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
    Lancet. 2024 May 17:S0140-6736(24)00537-3. doi: 10.1016/S0140-6736(24)00537.
    PubMed     Abstract available
    
    
    
58. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    PubMed     Abstract available
    
    
    
59. SACCO S, Turc G
    Advances and challenges in the acute treatment of minor ischaemic stroke.
    Lancet. 2024 May 16:S0140-6736(24)00981-4. doi: 10.1016/S0140-6736(24)00981.
    PubMed    
    
    
    
60. HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al
    Stroke.
    Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642.
    PubMed     Abstract available
    
    
    
61. BECK J, Fung C, Strbian D, Butikofer L, et al
    Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.
    Lancet. 2024 May 14:S0140-6736(24)00702-5. doi: 10.1016/S0140-6736(24)00702.
    PubMed     Abstract available
    
    
    
62. KLIJN CJ, Dammers R, Sprigg N
    Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes?
    Lancet. 2024 May 14:S0140-6736(24)00703-7. doi: 10.1016/S0140-6736(24)00703.
    PubMed    
    
    
    April 2024
63. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed     Abstract available
    
    
    
64. GE Z, Kan J, Gao X, Raza A, et al
    Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
    PubMed     Abstract available
    
    
    
65. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
    Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
    PubMed     Abstract available
    
    
    
66. 
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    PubMed     Abstract available
    
    
    March 2024
67. VAHL TP, Thourani VH, Makkar RR, Hamid N, et al
    Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Lancet. 2024 Mar 26:S0140-6736(23)02806-4. doi: 10.1016/S0140-6736(23)02806.
    PubMed     Abstract available
    
    
    
68. MELLO A, Stehr D, Bujarski K, Duchaine B, et al
    Visualising facial distortions in prosopometamorphopsia.
    Lancet. 2024;403:1176.
    PubMed    
    
    
    
69. 
    Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Mar 19:S0140-6736(24)00550-6. doi: 10.1016/S0140-6736(24)00550.
    PubMed     Abstract available
    
    
    
70. CHEN WG, Edwards E, Iyengar S, Finkelstein R, et al
    Music and medicine: quickening the tempo of progress.
    Lancet. 2024 Mar 18:S0140-6736(24)00477-X. doi: 10.1016/S0140-6736(24)00477.
    PubMed    
    
    
    
71. 
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed     Abstract available
    
    
    February 2024
72. CONSOLI A, Gory B
    Long-term results of mechanical thrombectomy for large ischaemic stroke.
    Lancet. 2024 Feb 8:S0140-6736(24)00158-2. doi: 10.1016/S0140-6736(24)00158.
    PubMed    
    
    
    
73. SARRAJ A, Abraham MG, Hassan AE, Blackburn S, et al
    Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.
    Lancet. 2024 Feb 8:S0140-6736(24)00050-3. doi: 10.1016/S0140-6736(24)00050.
    PubMed     Abstract available
    
    
    January 2024
74. BEN-SHLOMO Y, Darweesh S, Llibre-Guerra J, Marras C, et al
    The epidemiology of Parkinson's disease.
    Lancet. 2024;403:283-292.
    PubMed     Abstract available
    
    
    November 2023
75. FROST R, Avgerinou C, Kalwarowsky S, Mahmood F, et al
    Enabling health and maintaining independence for older people at home (HomeHealth trial): a multicentre randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S42.
    PubMed     Abstract available
    
    
    
76. BARRADO-MARTIN Y, Frost R, Catchpole J, Rookes T, et al
    Goal setting as part of a holistic intervention to promote independence in older people with mild frailty: a process evaluation alongside a randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S1.
    PubMed     Abstract available
    
    
    
77. LIU L, Li X, Marshall IJ, Bhalla A, et al
    Trajectories of depressive symptoms 10 years after stroke and associated risk factors: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S64.
    PubMed     Abstract available
    
    
    October 2023
78. MESSERLI FH, Bangalore S, Mandrola JM
    beta blockers switched to first-line therapy in hypertension.
    Lancet. 2023 Oct 13:S0140-6736(23)01733-6. doi: 10.1016/S0140-6736(23)01733.
    PubMed     Abstract available
    
    
    
79. DIPPEL DWJ, Roozenbeek B
    Thrombectomy for acute ischaemic stroke without advanced imaging.
    Lancet. 2023 Oct 10:S0140-6736(23)02229-8. doi: 10.1016/S0140-6736(23)02229.
    PubMed    
    
    
    
80. BENDSZUS M, Fiehler J, Subtil F, Bonekamp S, et al
    Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
    Lancet. 2023 Oct 10:S0140-6736(23)02032-9. doi: 10.1016/S0140-6736(23)02032.
    PubMed     Abstract available
    
    
    August 2023
81. MAKKAR RR, Kapadia S, Chakravarty T, Cubeddu RJ, et al
    Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.
    Lancet. 2023 Aug 31:S0140-6736(23)01636-7. doi: 10.1016/S0140-6736(23)01636.
    PubMed     Abstract available
    
    
    
82. MAJOIE CB, Cavalcante F, Gralla J, Yang P, et al
    Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials.
    Lancet. 2023 Aug 25:S0140-6736(23)01142-X. doi: 10.1016/S0140-6736(23)01142.
    PubMed     Abstract available
    
    
    
83. HANKEY GJ
    Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
    Lancet. 2023 Aug 25:S0140-6736(23)01202-3. doi: 10.1016/S0140-6736(23)01202.
    PubMed    
    
    
    
84. WILKOFF BL, Filippatos G, Leclercq C, Gold MR, et al
    Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
    Lancet. 2023 Aug 24:S0140-6736(23)00912-1. doi: 10.1016/S0140-6736(23)00912.
    PubMed     Abstract available
    
    
    July 2023
85. STRANDELL A, Hellgren M
    Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia.
    Lancet. 2023;402:6-7.
    PubMed    
    
    
    June 2023
86. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    PubMed     Abstract available
    
    
    May 2023
87. MA L, Hu X, Song L, Chen X, et al
    The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
    Lancet. 2023 May 24:S0140-6736(23)00806-1. doi: 10.1016/S0140-6736(23)00806.
    PubMed     Abstract available
    
    
    April 2023
88. WARDLAW JM
    Even more benefit with endovascular treatment for patients with acute ischaemic stroke: MR CLEAN-LATE.
    Lancet. 2023;401:1317-1319.
    PubMed    
    
    
    
89. HAWKEY C
    Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.
    Lancet. 2023;401:1266.
    PubMed    
    
    
    
90. GATTA L, Zullo A, Vaira D
    Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.
    Lancet. 2023;401:1265-1266.
    PubMed    
    
    
    
91. LI Y, Liang Z, Stone GW, Han Y, et al
    BRIGHT-4 trial: bivalirudin strikes back - Authors' reply.
    Lancet. 2023;401:1158.
    PubMed    
    
    
    
92. PIRIOU PG, Manigold T, Letocart V, Guerin P, et al
    BRIGHT-4 trial: bivalirudin strikes back.
    Lancet. 2023;401:1157-1158.
    PubMed    
    
    
    March 2023
93. OLTHUIS SGH, Pirson FAV, Pinckaers FME, Hinsenveld WH, et al
    Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase
    Lancet. 2023 Mar 29:S0140-6736(23)00575-5. doi: 10.1016/S0140-6736(23)00575.
    PubMed     Abstract available
    
    
    
94. KLOK FA, Siegerink B
    Ordinal outcomes add value to clinical trials.
    Lancet. 2023;401:995.
    PubMed    
    
    
    
95. HE J, Ouyang N, Guo X, Sun G, et al
    Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
    Lancet. 2023 Mar 2:S0140-6736(22)02603-4. doi: 10.1016/S0140-6736(22)02603.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.